Skip to main content
Feature Story

Branching out in pancreatic cancer

By Benjamin Boettner, Senior Writer

Branching out in pancreatic cancer

Predicting pancreatic cancer has been a major problem in the disease, which is normally too advanced for effective treatment by the time it is diagnosed. Researchers at the Massachusetts Institute of Technology and the Dana-Farber Cancer Institute have identified a prediagnostic signature of branched-chain amino acids that could help improve risk prediction up to five years before the disease appears, but developing a viable biomarker panel will require identification of the tumor factors that trigger the change.1

Full Article

Chilling Reality

Subscribe Now
Free Trial